200 related articles for article (PubMed ID: 8082891)
1. src-specific immunity in inbred chickens bearing v-src DNA- and RSV-induced tumors.
Plachý J; Hála K; Hejnar J; Geryk J; Svoboda J
Immunogenetics; 1994; 40(4):257-65. PubMed ID: 8082891
[TBL] [Abstract][Full Text] [Related]
2. src-specific immune regression of Rous sarcoma virus-induced tumors.
Gelman IH; Hanafusa H
Cancer Res; 1993 Feb; 53(4):915-20. PubMed ID: 8381333
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccination against v-src oncogene-induced tumours in congenic chickens.
Plachý JV; Hejnar JV; Trtková K; Trejbalová K; Svoboda J; Hála K
Vaccine; 2001 Aug; 19(31):4526-35. PubMed ID: 11483280
[TBL] [Abstract][Full Text] [Related]
4. v-src oncogene-specific carboxy-terminal peptide is immunoprotective against Rous sarcoma growth in chickens with MHC class I allele B-F12.
Hofmann A; Plachy J; Hunt L; Kaufman J; Hala K
Vaccine; 2003 Dec; 21(32):4694-9. PubMed ID: 14585677
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility (B) complex control of responses against Rous sarcomas.
Taylor RL
Poult Sci; 2004 Apr; 83(4):638-49. PubMed ID: 15109061
[TBL] [Abstract][Full Text] [Related]
6. Tumor induction by the LTR, v-src, LTR DNA in four B (MHC) congenic lines of chickens.
Svoboda J; Plachý J; Hejnar J; Karakoz I; Guntaka RV; Geryk J
Immunogenetics; 1992; 35(5):309-15. PubMed ID: 1348493
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of type I and type II interferons toward Rous sarcoma virus-induced tumors in chickens.
Plachý J; Weining KC; Kremmer E; Puehler F; Hala K; Kaspers B; Staeheli P
Virology; 1999 Mar; 256(1):85-91. PubMed ID: 10087229
[TBL] [Abstract][Full Text] [Related]
8. An analysis of the response of recombinant congenic lines of chickens to RSV challenge provides evidence for further complexity of the genetic structure of the chicken MHC (B).
Plachý J
Folia Biol (Praha); 1988; 34(3):170-81. PubMed ID: 2849569
[TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility (B) complex control of the growth pattern of v-src DNA-induced primary tumors.
Taylor RL; Ewert DL; England JM; Halpern MS
Virology; 1992 Nov; 191(1):477-9. PubMed ID: 1329333
[TBL] [Abstract][Full Text] [Related]
10. Suppression of Rous sarcoma virus-induced tumor formation by preinfection with viruses encoding src protein with novel N termini.
Gelman IH; Hanafusa H
J Virol; 1989 Jun; 63(6):2461-8. PubMed ID: 2542564
[TBL] [Abstract][Full Text] [Related]
11. Genes of chicken MHC regulate the adherence activity of blood monocytes in Rous sarcomas progressing and regressing lines.
Hala K; Moore C; Plachy J; Kaspers B; Böck G; Hofmann A
Vet Immunol Immunopathol; 1998 Nov; 66(2):143-57. PubMed ID: 9860187
[TBL] [Abstract][Full Text] [Related]
12. Endogenous c-src as a determinant of the tumorigenicity of src oncogenes.
Halpern MS; England JM; Kopen GC; Christou AA; Taylor RL
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):824-7. PubMed ID: 8570642
[TBL] [Abstract][Full Text] [Related]
13. Rous sarcoma virus does not induce sarcoma in early chick embryos by lack of the v-src gene expression.
Ogura H; Fujiwara T; Tanaka T
Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):477-82. PubMed ID: 1336425
[TBL] [Abstract][Full Text] [Related]
14. Tumor immunity generated in the course of regression of v-src-induced sarcomas.
Wisner TW; England JM; Pan DY; Stoker AW; Halpern MS
J Virol; 1991 Dec; 65(12):7020-4. PubMed ID: 1658394
[TBL] [Abstract][Full Text] [Related]
15. Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells.
Tatosyan A; Yatsula B; Shtutman M; Moinova E; Kaverina I; Musatkina E; Leskov K; Mizenina O; Zueva E; Calothy G; Dezélée P
Virology; 1996 Feb; 216(2):347-56. PubMed ID: 8607264
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility (B) complex control of the formation of v-src-induced metastases.
Taylor RL; England JM; Kopen GC; Christou AA; Halpern MS
Virology; 1994 Dec; 205(2):569-73. PubMed ID: 7975259
[TBL] [Abstract][Full Text] [Related]
17. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.
Verderame MF; Kaplan JM; Varmus HE
J Virol; 1989 Jan; 63(1):338-48. PubMed ID: 2462061
[TBL] [Abstract][Full Text] [Related]
18. The chicken--a laboratory animal of the class Aves.
Plachý J
Folia Biol (Praha); 2000; 46(1):17-23. PubMed ID: 10730878
[TBL] [Abstract][Full Text] [Related]
19. v-src induces clonal sarcomas and rapid metastasis following transduction with a replication-defective retrovirus.
Stoker AW; Sieweke MH
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10123-7. PubMed ID: 2557619
[TBL] [Abstract][Full Text] [Related]
20. Morphological transformation, tumorigenicity and src-specific cytotoxic T-lymphocyte-mediated tumor immunity induced by murine 3T3 cells expressing src oncogenes encoding novel non-myristylated N-terminal domains.
Gelman IH; Khan S; Hanafusa H
Oncogene; 1993 Nov; 8(11):2995-3004. PubMed ID: 7692370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
